Von Wiltman
Associate Director - Technical Operations Apertura Gene Therapy
Seminars
Thursday 26th February 2026
Manufacturing & QC Considerations for TfR1-Targeted AAV Capsids: Balancing Innovation with Process Robustness
9:00 am
- Identifying key bottlenecks in purification and how adjustments in chromatography and filtration improve recovery and yield
- Evaluating the role of advanced analytical methods in confirming identity and consistency
- Sharing lessons on establishing platform QC methods that remain predictive and reproducible when applied to engineered capsids
